Skip to main content
Clinical Trials/NL-OMON20448
NL-OMON20448Not yet recruitingNot Applicable

The Effects of a GABA Supplement Versus a Placebo on Glucose Tolerance and Blood Pressure in Prediabetics

TKI funded project with industrial sponsors Nunhems, Agrico Research and Avebe0 sites52 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
52

Study Overview

Brief Summary

n.a.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Age between 50 and 70
  • BMI higher or equal to 27 kg/m2
  • Impaired fasting glucose (fasting glucose = 5.6 and = 6.9 mmol/L) or/and
  • Impaired glucose tolerance (glucose levels = 7.8 and = 11.1 mmol/L, 2-hours after an OGTT or/and glucose levels =8.6 mmol/L, 1-hour after an OGTT)

Exclusion Criteria

  • Has been diagnosed with diabetes
  • Having other conditions, like liver, pancreatic, cardiovascular, gastro-intestinal or endocrine diseases, that could influence the study results
  • Use of medications or supplements that could influence the study results
  • Sensitive to medical skin adhesives
  • More than 5kg weight change in the past 12 weeks
  • Excessive alcohol consumption (>21 glasses/week for men and >14 glasses/week for women on average)
  • Being an employee of Wageningen University, division Human Nutrition and Health
  • Currently a research subject in other research

Investigators

Sponsor
TKI funded project with industrial sponsors Nunhems, Agrico Research and Avebe

Similar Trials

Intervention With a GABA Supplement in... | Clinical Trial